Scarica l'app Stockscreener
404.94
2.37%
-9.81
Pre-mercato:
411.10
6.16
+1.52%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMO Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$414.75
Aprire:
$414.94
Volume 24 ore:
2.73M
Relative Volume:
1.00
Capitalizzazione di mercato:
$152.86B
Reddito:
$42.90B
Utile/perdita netta:
$6.52B
Rapporto P/E:
23.75
EPS:
17.05
Flusso di cassa netto:
$6.72B
1 W Prestazione:
-4.80%
1M Prestazione:
+1.77%
6M Prestazione:
-29.34%
1 anno Prestazione:
-24.22%
Intervallo 1D:
$403.36
$415.00
Intervallo di 1 settimana:
$403.36
$429.00
Portata 52W:
$385.46
$627.88
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Nome
Thermo Fisher Scientific Inc
Settore
Industria
Telefono
(781) 622-1000
Indirizzo
168 THIRD AVENUE, WALTHAM, MA
Confronta TMO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
404.94 | 160.56B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
188.07 | 141.52B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
520.87 | 42.74B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
112.04 | 34.11B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
158.96 | 27.70B | 15.50B | 1.33B | 2.16B | 7.34 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Downgrade | UBS | Buy → Neutral |
| 2025-01-10 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-03-18 | Ripresa | Citigroup | Neutral |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Iniziato | HSBC Securities | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-10-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-09-06 | Ripresa | Citigroup | Buy |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-07-19 | Reiterato | Robert W. Baird | Outperform |
| 2023-07-13 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Reiterato | Barclays | Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Ripresa | Barclays | Overweight |
| 2021-10-20 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Reiterato | Needham | Buy |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-01-31 | Reiterato | Needham | Buy |
| 2020-01-22 | Iniziato | Credit Suisse | Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-25 | Reiterato | Needham | Buy |
| 2019-07-16 | Downgrade | Needham | Strong Buy → Buy |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-05-23 | Reiterato | Needham | Strong Buy |
| 2019-04-22 | Reiterato | Needham | Strong Buy |
| 2019-04-16 | Reiterato | BofA/Merrill | Buy |
Mostra tutto
Thermo Fisher Scientific Inc Borsa (TMO) Ultime notizie
Thermo Fisher (TMO) Reports Q2: Everything You Need To Know Ahead Of Earnings - FinancialContent
Thermo Fisher Scientific accelerates precision oncology research - Scientist Live
India In Vitro Diagnostics (IVD) Industry Analysis & Forecast (2025-2034) Featuring Roche, Transasia Bio-Medicals, Bio-Rad Labs, BioMerieux, Sysmex, Abbott, Thermo Fisher Scientific, QIAGEN, Quidel, Danaher - Yahoo Finance
Mass Spectrometry Company Evaluation Report 2025 | Agilent, Thermo Fisher, and Waters Lead with Robust Portfolios, Strategic Expansions, and Innovation-Driven Growth - Yahoo Finance
What drives Thermo Fisher Scientific Inc. stock priceSkyrocketing profit margins - jammulinksnews.com
What analysts say about Thermo Fisher Scientific Inc. stockFast-track wealth growth - Autocar Professional
Thermo Fisher Scientific’s (TMO) Dividend: Steady Payouts in a Growing Market - MSN
Is Thermo Fisher Scientific Inc. a good long term investmentHigh-impact investment strategies - Autocar Professional
Thermo Fisher Scientific (TMO) Announces Strategic Partnership Expansion With Sanofi - Insider Monkey
Thermo Fisher acquires Sanofi’s steriles manufacturing site in US - MSN
Thermo Fisher Scientific's Q2 2025 Earnings: Navigating Near-Term EPS Pressures With a High-Innovation Engine - AInvest
Thermo Fisher Scientific's Q2 2025 Earnings Outlook: Assessing Growth Resilience Amid EPS Declines and Strategic Momentum in Key Verticals - AInvest
Thermo Fisher Scientific Inc. Stock Analysis and ForecastSuperior returns - jammulinksnews.com
Thermo Fisher acquires Sanofi's New Jersey manufacturing site - MSN
Lobbying Update: $400,000 of THERMO FISHER SCIENTIFIC INC lobbying was just disclosed - Quiver Quantitative
Thermo Fisher Scientific Inc. (NYSE:TMO) Q1 2025 Earnings Call Transcript - MSN
Thermo Fisher Scientific Trading Volume Ranks 84th Amid Price Target Cut - AInvest
Thermo Fisher (TMO) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates - MSN
Thermo Fisher, Exact Sciences, Integer Holdings, Revvity, and 10x Genomics Shares Are Falling, What You Need To Know - Yahoo Finance
13 Best Long Term Low Volatility Stocks to Buy Now - Insider Monkey
Pharma Contract Research Organization (CRO) Services Market to Cross USD 36.66 Billion in 2025, Expanding at a CAGR of 10.04% - GlobeNewswire Inc.
TMO to Report Q2 Earnings: Analytical Instruments Segment in Focus - TradingView
How the Digital Genome Market Will Evolve by 2032Growth, - openPR.com
Thermo Fisher and Sanofi Expand Strategic Partnership to Enable US Drug Manufacturing - CHEManager
Favorable Government Support Fuels Germany's Biotech Innovation and Commercialization: Market to Surpass USD 94 Billion by 2034 Led by QIAGEN, Thermo Fisher Scientific, Illumina and Roche - GlobeNewswire
Thermo Fisher Scientific Ranks 98th in Trading Volume with 10.51 Billion as Stock Price Surges 2.08 - AInvest
Thermo Fisher Acquires Sanofi’s Ridgefield Facility to Produce Essential Medicines - geneonline.com
Thermo Fisher Scientific's Options: A Look at What the Big Money is Thinking - Nasdaq
Thermo Fisher Agrees to Acquire Sanofi’s Steriles Manufacturing Site - Genetic Engineering and Biotechnology News
Thermo Fisher Scientific, SAMRC, DSTI launch new scientific training facility - Engineering News
Thermo Fisher to Acquire Sanofi's Ridgefield Sterile Manufacturing Site - PharmiWeb.com
Thermo Fisher Scientific and Sanofi Expand Strategic Partnership to Enable Additional U.S. Drug Product Manufacturing - BioSpace
Thermo Fisher to acquire Sanofi’s steriles manufacturing site in US to produce critical medicines - BioSpectrum Asia
Thermo Fisher Scientific Inc. Ranks 83rd in Trading Volume with 11.51 Billion Shares Exchanged Amid Acquisition News and Strong Financial Results - AInvest
Thermo Fisher and Sanofi Expand Partnership to Enable Manufacturing - New Jersey Business Magazine
Thermo Fisher Scientific price target lowered to $550 by TD Cowen - Investing.com
Sanofi, Thermo Fisher announce partnership to boost US manufacturing - WFMZ.com
Thermo Fisher bolsters US fill-finish capacity with Sanofi plant purchase - Fierce Pharma
Analysts Estimate Thermo Fisher Scientific (TMO) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Thermo Fisher acquires Sanofi’s New Jersey manufacturing site By Reuters - Investing.com
Thermo Fisher Acquires Sanofi's New Jersey Manufacturing Site - US News Money
Thermo Fisher Scientific, Sanofi Expand Strategic Partnership - Contract Pharma
Thermo Fisher Scientific Signs Deal To Buy Sanofi's Steriles Manufacturing Site In Ridgefield - Nasdaq
Thermo Fisher to buy Sanofi's U.S. production site (TMO:NYSE) - Seeking Alpha
Thermo Fisher to acquire Sanofi’s sterile manufacturing site in New Jersey - Investing.com
Thermo Fisher Scientific introduces the Oncomine Comprehensive Assay Plus on the Ion Torrent Genexus System - SelectScience
Thermo Fisher Scientific's Trading Volume Drops 26.9% Ranking 96th Amid Manufacturing Expansion and Innovation Push - AInvest
Thermo Fisher Scientific Inc Azioni (TMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.04%
1.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):